General Information of This Antigen (ID: TAR0CYSHF)
Antigen Name
Interleukin-2 receptor subunit alpha (IL2RA)
Gene Name
IL2RA
Gene ID
3559
Synonym
TAC antigen;p55;CD25
Sequence
MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKS
GSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQSPMQPVDQAS
LPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALHRGPAESVCKMTHGKTRWTQP
QLICTGEMETSQFPGEEKPQASPEGRPESETSCLVTTTDFQIQTEMAATMETSIFTTEYQ
VAVAGCVFLLISVLLLSGLTWQRRQRKSRRTI

    Click to Show/Hide
Function
Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells.

    Click to Show/Hide
Uniprot Entry
IL2RA_HUMAN
HGNC ID
HGNC:6008
KEGG ID
hsa:3559
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
A detuned-affinity anti-CD25 mAb
ADC Name Payload Target Linker ADC Info
PF-08046032 [1]
Monomethyl auristatin E
Microtubule (MT)
Mc-Val-Cit-PABC
Camidanlumab
ADC Name Payload Target Linker ADC Info
Camidanlumab tesirine
SG3199 (SC-DR002)
Human deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Undisclosed
ADC Name Payload Target Linker ADC Info
RM-1995
IRDye 700DX
Undisclosed
Undisclosed
Anti-cancer therapy (Philogen/Pfizer) [2]
Undisclosed
Undisclosed
Undisclosed
References
Ref 1 PF-08046032: A Novel, Investigational CD25-Directed Antibody-Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
Ref 2 Philogen announces option and license agreement with Pfizer to develop and commercialize multiple antibody drug conjugates and targeted nanoparticles; 2014